Overview

A Clinical Study Evaluating the Safety and Efficacy of IDP-115 in Patients With Rosacea

Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and effectiveness of IDP-115 in treating patients with rosacea.
Phase:
Phase 2
Details
Lead Sponsor:
Dow Pharmaceutical Sciences